Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

DCTH stock hub

Delcath Systems, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

DCTHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
395.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
DCTH
In the news

Latest news · DCTH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/E705.3
P25 14.9P50 23.2P75 38.5
ROE0.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-3
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All DCTH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
USD
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0000872912
Company name
Delcath Systems, Inc.
Country
United States
Country code
US
Cusip
24661P807
Employees
156
Employees Change
60%
Employees Change Percent
62.5
Enterprise value
$307.3M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
Isin
US24661P8077
Last refreshed
2026-05-10
Market cap
$395.7M
Market cap category
Small-Cap
Price
$11.48
Price currency
USD
Rev Per Employee
579,750x
Sector
Healthcare
Sic
3841
Symbol
DCTH
Website
https://www.delcath.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
0.14%
EV Earnings
547.71x
EV Sales Forward
2.71x
EV/Sales
3.4x
P/B ratio
3.51x
P/E ratio
705.27x
P/S ratio
4.37x
PS Forward
3.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-1.79%
EBITDA Margin
-1.51%
Gross margin
85.97%
Gross Profit
$77.8M
Gross Profit Growth
70.06%
Gross Profit Growth Q
25.5%
Gross Profit Growth3 Y
233.09%
Gross Profit Growth5 Y
135.83%
Net Income
$561,000
Net Income Growth Years
2%
Pretax Margin
1.48%
Profit Margin
0.62%
Profit Per Employee
$3,596
Profitable Years
1
ROA
-0.95
Roa5y
-45.16
ROCE
-1.42
ROE
0.58
Roe5y
-404.2
ROIC
-2.99
Roic5y
-1,636

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-83.09%
Cagr1y
-1.12%
Cagr3y
23.87%
Cagr5y
1.08%
EPS Growth Years
3
Revenue Growth
67.95x
Revenue Growth Q
26.33x
Revenue Growth Quarters
9x
Revenue Growth Years
2x
Revenue Growth3 Y
213.4x
Revenue Growth5 Y
120.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.85
Assets
$124.8M
Cash
$89.3M
Current Assets
$120.3M
Current Liabilities
$10.7M
Debt
$907,000
Debt Equity
$0.01
Equity
$112.7M
Liabilities
$12.1M
Long Term Assets
$4.6M
Long Term Liabilities
$1.4M
Net Cash
$88.4M
Net Cash By Market Cap
$22.34
Net Cash Growth
52.72%
Net Debt Equity
$-0.78
Tangible Book Value
$112.7M
Tangible Book Value Per Share
$3.27
WACC
7.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
11.24
Inventory Turnover
1.5
Net Working Capital
$20.4M
Quick ratio
9.67
Working Capital
$109.6M
Working Capital Turnover
$0.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-26.16%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

41
MetricValue
10Y total return
-100%
1Y total return
-1.12%
200-day SMA
10.19
3Y total return
90.07%
50-day SMA
9.95
50-day SMA vs 200-day SMA
50under200
5Y total return
5.52%
All Time High
8,980,000,000
All Time High Change
-100%
All Time High Date
2014-04-10
All Time Low
2.25
All Time Low Change
410.22%
All Time Low Date
2023-11-14
ATR
0.49
Beta
0.53
Beta1y
1.63
Beta2y
1.67
Ch YTD
13.66
High
11.49
High52
18.23
High52 Date
2025-05-20
High52ch
-37.03%
Low
11.03
Low52
8.12
Low52 Date
2025-11-20
Low52ch
41.38%
Ma50ch
15.34%
Premarket Change Percent
0.69
Premarket Price
$11.32
Premarket Volume
300
Price vs 200-day SMA
12.66%
RSI
64.04
RSI Monthly
16.88
RSI Weekly
60.01
Sharpe ratio
0.18x
Sortino ratio
0.39
Total Return
-26.16%
Tr YTD
13.66
Tr1m
18.72%
Tr1w
6.3%
Tr3m
22.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
4
Analyst Count Top
2
Analyst Price Target Top
$24
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.08
Earnings Revenue Estimate
23,745,464x
Earnings Revenue Estimate Growth
19.93x
Operating Income
$-1.6M
Operating margin
-1.79
Price target
$22
Price Target Change
$91.64
Price Target Change Top
$109

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
28,533,686%
Float Percent
82.79%
Shares Insiders
7.6%
Shares Institutions
38.89%
Shares Out
34,465,087
Shares Qo Q
-1.17%
Shares Yo Y
26.16%
Short Float
13.53%
Short Ratio
12.82
Short Shares
11.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Average Volume
351,376.75x
Bv Per Share
3.27
Ch10y
-100
Ch1m
18.72
Ch1w
6.3
Ch1y
-1.12
Ch3m
22.52
Ch3y
90.07
Ch5y
5.52
Ch6m
32.87
Change
2.14%
Change From Open
1.06
Close
11.24
Days Gap
1.07
Depreciation Amortization
254,500
Dollar Volume
6,539,398.3
Earnings Date
2026-05-07
Earnings Time
bmo
EBIT
$-1.6M
EBITDA
$-1.4M
EPS
$0.01
F Score
2
Fiscal Year End
December
Founded
1,988
Graham Number
0.99785
Graham Upside
-91.31
Income Tax
$777,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2019-12-24
Last Split Type
Reverse
Last10k Filing Date
2026-02-26
Ma150
9.94
Ma150ch
15.46%
Ma20
10.88
Ma20ch
5.54%
Next Earnings Date
2026-08-05
Open
11.36
Optionable
Yes
Position In Range
97.83
Post Close
11.48
Postmarket Change Percent
-0.09
Postmarket Price
$11.47
Ppne
4,569,000
Pre Close
11.24
Price Date
2026-05-08
Ptbv Ratio
3.51
Relative Volume
1.62x
Revenue
90,441,000x
Tax By Revenue
0.86x
Tax Rate
58.07%
Tr6m
32.87%
Us State
New York
Volume
569,634
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does DCTH pay a dividend?

Capital-return profile for this ticker.

Performance

DCTH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-1.1%
S&P 500 1Y: n/a
3Y total return
+90.1%
S&P 500 3Y: n/a
5Y total return
+5.5%
S&P 500 5Y: n/a
10Y total return
-100.0%
S&P 500 10Y: n/a
Ownership

Who owns DCTH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+38.9%
Float: +82.8% of shares outstanding
Insider ownership
+7.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+13.5%
12.8 days to cover
Y/Y dilution
+26.2%
Negative means the company is buying back shares.
Technical

DCTH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.0
Neutral momentum band
Price vs 200-day MA
+12.7%
50/200-day relationship not available
Beta (5Y)
0.53
Less volatile than the market
Sharpe ratio
0.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About DCTH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DCTH stock rating?

Delcath Systems, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DCTH analysis?

The full report lives at /stocks/DCTH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DCTH?

The latest report frames DCTH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DCTH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.